Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: A case series

Cases Journal

Volumn 2, Issue 2, 2009, Pages

  Aretha, Diamanto ^a   Panteli, Eleftheria S ^a   Kiekkas, Panagiotis ^a   Karanikolas, Menelaos ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; LEVOBUPIVACAINE; MIDAZOLAM; MORPHINE;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; FAMILY; FEMALE; HUMAN; INFUSION PUMP; MALE; PATIENT CONTROLLED ANALGESIA; SEDATION; SYMPTOM; WAKEFULNESS;

EID: 77953409978     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-136     Document Type: Article

References (17)

1. Kohara H, Ueoka H, Takeyama H, Murakami T, Morita T: Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med 2005, 8(1):20-25 (Pubitemid 40144248)
2. Miccinesi G, Rietjen JA, Deliens L, Paci E, Bosshard G, Nilstum T, Norup M, Wal G Van der, EURELD, consortium: Continuous deep sedation: physicians experiences in six European countries. J Pain Symptom Manage 2006, 31(2):122-129 (Pubitemid 43243665)
3. Morita T, Tsuneto S, Shima Y: Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 2002, 24(4):447-453 (Pubitemid 36020488)
4. Billings JA, Block SD: Slow euthanasia. J Palliat Care 1996, 12:21-30.
5. Burke AL, Diamond PL, Hulbert J, Yeatman J, Farr EA: Terminal restlessness - its management and the role of midazolam. Med J Aust 1991, 155:485-487.
6. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachem T: Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991, 7:5-11.
7. Morita T, Inoue S, Chihara S: Sedation for symptom control in Japan: The importance of intermittent use and communication with family members. J Pain Symptom Manage 1996, 12:32-38. (Pubitemid 26187522)
8. Ventafridda V, Ripamonti C, DeConno F, Tamburini M: Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990, 6:7-11.
9. Morita T, Ikenaga M, Adachi I, Narabayashi I, Kizawa Y, Honke Y: Family experience with palliative sedation therapy for terminally ill cancer patients. J Pain Symptom Manage 2004, 28:557-565 (Pubitemid 39626100)
10. Morita T: Palliative sedation to relieve psycho-existential suffering of terminally ill cancer patients. J Pain Symptom Manage 2004, 28:445-450 (Pubitemid 39422483)
11. Cowan DJ, Walsh D: Terminal sedation in palliative medicine - definition and review of the literature. Support Care Cancer 2001, 9:403-407. (Pubitemid 32843627)
12. Morita T, Tsunoda J, Inoue S, Chihara S: The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999, 7:128-133 (Pubitemid 29187559)
13. Clemens KE, Klaschik E: Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Support Care Cancer 2008, 16:93-99. (Pubitemid 350243764)
14. Sessler CM, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA, Tesoro EP, Elswick RK: The Richmond Agitation - Sedation scale: validity and reliability in adult intensive care unit patients. Am J Resp Crit Care Med 2002, 166:1338-1344.
15. Lo B, Rubenfeld G: Palliative sedation in dying patients: "we turn to it when everything else hasn't worked". JAMA 2005, 294:1810-1816
16. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY: Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 2001, 21:467-472
17. McIver B, Walsh D, Nelson K: The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 1994, 9:341-345. (Pubitemid 24241429)